Gene · 5476
Papers2,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monogenic causes of cerebral small vessel disease and stroke. | Handb Clin Neurol | 2024 | 39322384 | PubTator, text mining | PubMed |
| Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial. | Nat Commun | 2024 | 39138212 | PubTator, text mining | PubMed |
| Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti-Obesity Cyclic Peptide. | Chemistry | 2024 | 39115037 | PubTator, text mining | PubMed |
| Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity. | J Lipid Res | 2024 | 39084491 | PubTator, text mining | PubMed |
| Creation of an in vitro model of GM1 gangliosidosis by CRISPR/Cas9 knocking-out the GLB1 gene in SH-SY5Y human neuronal cell line. | Cell Biochem Funct | 2024 | 39076066 | PubTator, text mining | PubMed |
| A novel basement membrane-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma. | Front Oncol | 2024 | 39070142 | PubTator, text mining | PubMed |
| Elusive Protein-Glycosphingolipid Interactions Revealed by Membrane Anchor-Assisted Native Mass Spectrometry. | J Am Chem Soc | 2024 | 39052014 | PubTator, text mining | PubMed |
| Pharmacogenomics: Challenges and Future. | Genes (Basel) | 2024 | 38927650 | PubTator, text mining | PubMed |
| Comprehensive evaluation of genes related to basement membrane in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38870261 | PubTator, text mining | PubMed |
| Unraveling the Regimes of Interfacial Thermal Conductance at a Solid/Liquid Interface. | J Phys Chem C Nanomater Interfaces | 2024 | 38807631 | PubTator, text mining | PubMed |
| AAV-mediated gene therapy for sialidosis. | Mol Ther | 2024 | 38796704 | PubTator, text mining | PubMed |
| Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics. | Drug Metab Dispos | 2024 | 38777597 | PubTator, text mining | PubMed |
| Glycosphingolipids in Osteoarthritis and Cartilage-Regeneration Therapy: Mechanisms and Therapeutic Prospects Based on a Narrative Review of the Literature. | Int J Mol Sci | 2024 | 38732111 | PubTator, text mining | PubMed |
Differential Bioactivation Profiles of Different GS-441524 Prodrugs in Cell and Mouse Models: ProTide Prodrugs with High Cell Permeability and Susceptibility to Cathepsin A Are More Efficient in Delivering Antiviral Active Metabolites to the Lung. | J Med Chem | 2024 | 38690769 | PubTator, text mining | PubMed |
| Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo. | J Biol Chem | 2024 | 38663826 | PubTator, text mining | PubMed |
| Altered GM1 catabolism affects NMDAR-mediated Ca2+ signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis model. | Cell Rep | 2024 | 38630590 | PubTator, text mining | PubMed |
| Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses. | Cardiovasc Diabetol | 2024 | 38614964 | PubTator, text mining | PubMed |
| Phacoemulsification combined with goniosynechialysis versus phacoemulsification alone for patients with primary angle‑closure disease: A meta-analysis. | PLoS One | 2024 | 38306318 | PubTator, text mining | PubMed |
| Serum antibody screening using glycan arrays. | Chem Soc Rev | 2024 | 38305761 | PubTator, text mining | PubMed |
| An early diagnosed cerebral small vessel disease in a 12-year-old girl. | Heliyon | 2024 | 38298677 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5476/papers?page=7